Registration Frequencies

Weekly updated frequencies of observation starts at registration by medication are shown.

Fig 1) Patient numbers by biologic treatment at inclusion
Last update: 25. March| total n= 26,833
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: 25. March| total n= 26,833
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1093 1594
Bimekizumab 458 0
Brodalumab 604 0
Certolizumab 247 0
Efalizumab 35 0
Etanercept 312 72
Golimumab 25 0
Guselkumab 2130 0
Infliximab 102 1
Ixekizumab 1113 0
Risankizumab 2160 0
Secukinumab 2233 0
Tildrakizumab 1850 0
Ustekinumab 784 43
Apremilast 799 0
Ciclosporin 402 0
Deucravacitinib 290 0
Fumaric acid esters 2694 0
Dimethyl fumarate 3501 0
Methotrexate 3924 0
Tofacitinib 2 0
Upadacitinib 9 0
other systemics 356 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: 25. March| total n= 26,833
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: 25. March | total n= 26,833
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: 18. March | n= 1,209 | updated monthly
Fig. 5) Registered PsoBest centers